Margin of Insight
← Free primer

Investment Memorandum · Preview

For informational purposes only. Not investment advice.

GE Aerospace

GE

NEUTRAL

May 23, 2026

Research Conclusion

GE Aerospace at $291.24 is fairly valued to modestly overvalued relative to a base-case fair-value range of $230–$340 (midpoint ~$285). The fundamental thesis—ultra-wide moat, generational LEAP aftermarket cycle, exceptional capital allocation under Culp—is fully intact and strengthening. However, the stock has moved +25% since November 2025 while underlying execution has not justified the rerating. Probability-weighted 2-year return is +3% total (~1.5% annually), below the 9.2% WACC. Verdict: HOLD, with strong watchlist priority for a pullback into the $225–260 zone.

Company Overview & Moat Assessment

GE Aerospace (NYSE: GE) is the world's largest jet engine manufacturer, formed as the pure-play successor to General Electric after the multi-year breakup that spun off GE HealthCare (Jan 2023) and GE Vernova (Apr 2024). The company operates two segments: Commercial Engines & Services (~80% of revenue)—including the LEAP engine (CFM International JV, the best-selling commercial engine in history, powering A320neo, 737 MAX, COMAC C919), the GE90/GE9X (sole-source on Boeing 777/777X), and a massive aftermarket business; and Defense & Propulsion Technologies (~20%)—including F110, F404/F414, T700 helicopter, and XA100 adaptive cycle engine. CEO Larry Culp has overseen one of the great industrial turnarounds (+3,600% since spinoff). The ~50,000 commercial engines in service generate decades of high-margin aftermarket revenue; LEAP install base set to roughly triple between 2024-2030, creating powerful services revenue ramp.

▲ Bull Case

  • ◆LEAP shop-visit ramp accelerates above consensus. The 2020-2024 vintage cohort hitting first shop visit 2026-2029 could produce +18-22% services growth (vs. +14% base case). Bull scenario reflects FY28 EPS $14.00 at 32x = $448/share, +54% from spot.
  • ◆LEAP OE margin reaches 6%+ by FY2028. Structural inflection more powerful than consensus assumes. Each 100bps of LEAP OE margin = ~$180M incremental adjusted operating profit ≈ $0.13 EPS. Reaching 6% by FY28 (vs. 4% base) implies ~$1.00+ incremental EPS not yet in consensus.
  • ◆Multiple holds at 35-40x through FY2028. The ultra-wide moat plus visible compounding justifies quality premium that does not normalize as growth decelerates. Install-base annuity model genuinely deserves higher quality multiple than typical industrial. If multiple holds at 32-35x on FY28 EPS $11.90, that implies $381-417 per share, +31-43% upside.

▼ Bear Case

  • ◆Boeing 737 MAX production stuck below 30/month through FY2027. Gap from 28 (May 2026) to 38 monthly target requires sustained operational execution not yet demonstrated. Each -8 monthly delivery gap = ~100-150 fewer LEAP OEs/year. Delays future shop-visit cohort by 1-2 years, materially damaging FY28-30 service revenue and pushing peak from 2028-2032 to 2030-2034.
  • ◆Multiple compresses from 40x to 25-28x. At 40x forward P/E in a 4.5% rate environment, cushion is razor-thin. Each 50bps rate rise compresses fair P/E ~2-3x. A 25-28x range on FY26E EPS $7.20 = $180-200/share — a 30-40% drawdown with no fundamental impairment, pure sentiment/discount-rate risk.
  • ◆Shop-visit deferral risk in near-term recession. Airlines have ±1-2 year flexibility on shop-visit timing in soft demand environments. A -10-15% shop-visit volume miss = -$1.0-1.5B CES services revenue, -$0.50-0.80 EPS. Crowded long position (85-90% institutional ownership) creates forced-selling risk at 40x multiple on any miss.
Primary Debate on Wall Street

“The defining debate: Is the current ~40x forward P/E justified by services flywheel durability and OE-to-AS mix progression, or is the 'best aerospace pure-play' framing fully priced after the 3x+ run since spinoff? Bull side (consensus PT $349, ~70% Buy ratings) argues LEAP install-base is a 10-year visible compounder deserving pharma-royalty multiples (30-40x indefinitely); Culp's +3,600% track record warrants permanent quality premium; LEAP OE inflection is one-time structural margin lift not yet in consensus. Bear side argues multiple compression is the primary risk, not earnings risk. At 40x with 4.5% risk-free rate, every 50bps rate normalization compresses fair multiple ~2-3x. Reverse DCF shows market is implying 14-16% EPS CAGR for 7-10 years—at or above the historical ceiling for aerospace peer set. Bear thesis is not that GE will fail but that price has discounted success in full. Consensus increasingly nervous about valuation: 21-analyst breakdown is 15 Buy / 3 Outperform / 2 Hold / 1 Underperform.”

Top Catalysts
  • ◆Q2 2026 Earnings (July 2026): Second guidance raise validates LEAP OE inflection; miss triggers multiple compression risk.
  • ◆LEAP shop visit disclosures (quarterly): >1,500/yr in FY2027 validates variant case; <1,200/yr signals deferred maintenance.
  • ◆Boeing 737 MAX production rate disclosure (quarterly): 35+/month sustained confirms OE volume; <28/month confirms cohort push-out.
  • ◆FY2026 Adjusted EPS print (Feb 2027): >$7.50 confirms beat cadence; <$7.00 disappoints market expectations.
  • ◆XA100 AETP award decision (2026-2027): GE win validates DPT growth leg; P&W win leaves DPT flat.
  • ◆Boeing 777X entry-into-service (H2 2026-2027): First GE9X commercial delivery unlocks new widebody revenue stream.
Top Risks
  • ◆R-07: Multiple compression from 40x to 25-28x (40% probability, 2yr). Pure valuation risk uncorrelated to GE execution. Each 50bps rate rise compresses fair P/E ~2-3x. Downside: -$70-90/share (-25-30%).
  • ◆R-01: Boeing 737 MAX stuck <30/month (45% probability, 2yr). Each -8 monthly gap delays LEAP OE volumes and pushes future shop-visit cohort right by 1-2 years, materially damaging services trajectory.
  • ◆R-03: LEAP shop visit volume miss in recession (20% probability, 2yr). Airlines can defer ±1-2 years. A -10-15% miss = -$0.50-0.80 EPS; crowded long position creates forced-selling risk at 40x.
  • ◆R-10: Aviation safety incident involving LEAP fleet (5% probability, 2yr, VERY HIGH impact). LEAP has flawless record but any first incident triggers sentiment cascade similar to 737 MAX 2019; stock could compress 40-60% in days.
  • ◆R-02: Pratt & Whitney GTF reliability fully restored (30% probability, post-2028 impact). Post-2028 cohort selection could rebalance away from LEAP; shapes terminal value but not current valuation.
  • ◆R-09: Culp departure without clear succession (15% probability, 2yr). Multiple compression on sentiment; 20-30% drawdown possible before fundamentals change.

Full Memo Continues

5 more sections, locked

  • ●
    Valuation Range & DCF
    Base/bull/bear fair-value range, WACC, terminal growth, sensitivity to revenue + margin assumptions.
  • ●
    Risk/Reward Assessment
    Position-sizing framework with explicit upside/downside skew and entry conditions.
  • ●
    Management & Capital Allocation
    Multi-year capital-allocation track record, incentive alignment, and management readout.
  • ●
    Monitoring Framework
    What to watch each quarter — leading indicators and inflection signals tracked by the analyst.
  • ●
    Unresolved Questions
    Open analyst questions and follow-up research items — the depth signal.

For Agents — $2 per memo

Call the JSON API with a Stripe Shared Payment Token. No account, no signup — just pay and call.

GET /api/v1/research/GE/memo
Authorization: Bearer spt_...

Fund managers — coverage subscriptions launching soon. See marginofinsight.com.

Margin of Insight

For informational purposes only. Not investment advice.